BANK OF AMERICA CORP /DE/
BankPosition in TRDA — Entrada Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in TRDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$426,342
-$68,513 QoQ
Shares Held
57,927
+47.7% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. TRDA ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $426,342 | 57,927 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $494,855 | 39,212 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $678,263 | 65,979 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $733,397 | 126,448 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $245,098 | 36,473 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $243,193 | 26,902 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $617,616 | 35,721 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $544,294 | 34,061 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $412,252 | 28,930 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $319,745 | 22,565 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $413,918 | 27,430 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $368,834 | 23,344 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $330,324 | 21,818 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $489,679 | 33,771 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $71,601 | 5,296 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $62,504 | 3,966 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $158,230 | 12,991 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $195,978 | 20,871 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $391,054 | 22,842 | Shares | Defined | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||